Stay updated on Pembrolizumab for Lung Cancer Prevention Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab for Lung Cancer Prevention Clinical Trial page.

Latest updates to the Pembrolizumab for Lung Cancer Prevention Clinical Trial page
- Check4 days agoChange DetectedRevision updated from v3.6.3 to v3.6.4, indicating a platform/software upgrade for the page. The change represents an internal version bump rather than a modification to study details or visible content.SummaryDifference0.1%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedRevision label updated from v3.6.2 to v3.6.3, signaling a newer page revision. This reflects a minor maintenance update to the page or its templates rather than a substantive change to study details.SummaryDifference0.1%

- Check32 days agoChange DetectedRevision tag updated from v3.6.0 to v3.6.2, signaling a new build or patch of the page. This update appears to be a maintenance/versioning change rather than a modification to the trial details or user-facing content.SummaryDifference0.1%

- Check46 days agoChange DetectedThe recruitment status was updated to indicate enrollment has closed ('No longer looking for participants'). The page also introduces or updates several help and navigation sections, standardizes the Intervention/Treatment heading, and updates the revision tag to v3.6.0.SummaryDifference0.4%

- Check53 days agoChange DetectedThe page revision updated from v3.5.4 to v3.5.5. This appears to be a minor software update with no visible changes to study details or content.SummaryDifference0.1%

- Check75 days agoChange DetectedThe page’s revision label was updated from v3.5.3 to v3.5.4, indicating a minor update to the page content.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab for Lung Cancer Prevention Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Lung Cancer Prevention Clinical Trial page.